Skip to main content
Genesystem Co., Ltd logo

Genesystem Co., Ltd — Investor Relations & Filings

Ticker · 363250 ISIN · KR7363250002 KO Manufacturing
Open in API
Filings indexed 173 across all filing types
Latest filing 2021-11-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 363250

About Genesystem Co., Ltd

https://genesystem.co.kr/

Genesystem Co., Ltd. is a biotechnology engineering company specializing in the development and commercialization of molecular diagnostic solutions for point-of-care testing (POCT) applications. The company focuses on making Polymerase Chain Reaction (PCR) testing faster, simpler, and more accessible for on-site use. It develops and markets rapid PCR platforms, proprietary reagents, and biochip-based products. Key technologies include ultra-fast PCR, miniaturized heating modules, and multiplex biochip systems that enable precise and convenient analysis. Genesystem's solutions serve various markets, including human healthcare for pathogen detection and food safety for identifying foodborne pathogens and meat authentication.

Recent filings

Filing Released Lang Actions
분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 진시스템' (Genesystem Co., Ltd.) covering the period from 2021-01-01 to 2021-09-30. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which are characteristic of a formal quarterly financial report. It is not an announcement of a report, but the report itself. 9M 2021
2021-11-15 Korean
기타경영사항(자율공시)(체외진단의료기기 제조인증 획득)
Regulatory Filings Classification · 100% confidence The document is a voluntary disclosure ('자율공시') regarding the acquisition of a medical device manufacturing certification for a real-time PCR system. It does not fit into specific categories like financial reports, board changes, or shareholder meetings. As it is a regulatory announcement of a business development/operational milestone that does not fall into the other specific categories, it is classified as a general regulatory filing.
2021-10-29 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Genesystem Co., Ltd.' covering the period from January 1, 2021, to June 30, 2021. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which is characteristic of an Interim/Quarterly Report (IR). H1 2021
2021-08-17 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership by Stonebridge Ventures Inc. and its special related parties in the company 'Jin System'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant changes in ownership levels.
2021-07-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the change in shareholding percentage (from 5.53% to 4.60%) by '이노폴리스파트너스(유)' in the company '(주)진시스템'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks significant ownership changes and threshold crossings.
2021-07-09 Korean
기타경영사항(자율공시)(체외진단의료기기 제조품목 허가)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure from a Korean company (GeneSystem) regarding the receipt of a medical device manufacturing approval from the Ministry of Food and Drug Safety. It is a voluntary disclosure of a specific business event (product approval) rather than a financial report, proxy, or meeting material. Since it does not fit into specific categories like M&A, dividends, or share transactions, it falls under the general regulatory filing category.
2021-07-08 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.